The MPN Symptom Masterclass with Dr. John Mascarenhas image

The MPN Symptom Masterclass with Dr. John Mascarenhas

Feb 25, 2026
12:30PM - 01:30PM EST
Online Event
Overview

Join the HealthTree Foundation for this symptom-focused webinar, with one of the most respected MPN specialists in the country Dr. John Mascarenhas. This event will focus on common symptoms that those living with polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF) face. This is a wonderful opportunity to hear from and ask questions to a leading expert in the MPN space.

 

 

 

Agenda
12:30 PM
Introductions
Dalton Bean

Dalton introduces the agenda of the event and featured speaker Dr. John Mascarenhas

12:35 PM
Presentation
John Mascarenhas, MD

Dr. John Mascarenhas talks about symptoms and solutions for MPN patients

1:05 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Dalton Bean

Dalton Bean

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Healthtree contact John Mascarenhas, MD

John Mascarenhas, MD

John Mascarenhas, MD, is a Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Mascarenhas is the Director of the Center of Excellence for Blood Cancers and Myeloid Disorders, directs the Adult Leukemia Program, and is a member of The Tisch Cancer Institute. His clinical and research focus centers around myeloproliferative neoplasms (MPNs) and acute myeloid leukemia (AML). Throughout his illustrative career, Dr. Mascarenhas has published over 275 papers, is the principal investigator for the National Cancer Institute sponsored Myeloproliferative Disease Research Consortium, and has served as principal investigator or study chair on numerous clinical trials geared toward innovative treatment approaches for MPNs and AML. Dr. Mascarenhas is widely recognized for his work in MPNs and is often invited to speak at conferences for his expertise in the field.